Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Kromek celebrating milestone week

Radiation technology company Kromek Group PLC (LON:KMK) has completed the delivery of an initial 10,000 personal D3S radiation detectors to a US Department of Defense agency. Also, on Monday they announced six new contracts wins worth, in aggregate, around US$3.1mln.

Chief executive Dr Arnab Basu tells Proactive: ''We've worked with the US department of Defense for the last seven years and we feel very proud we've been able to make a material contribution to their mission goals.''

''There'll be a deployment in Washington DC later on this year and further deployments are planned in 2017/2018 - with 2018 being the expected wider rollout within the federal states in the US.'' Dr Basu added.

With regard to the contract wins, he said fundamentally some of them are very important for us because  it demonstrates the real progress in all the sectors we operate in - medical, security and nuclear.

This week Kromek also won an award for business innovation. It was handed out on Tuesday night at the Palace of Westminster – commonly known as the Houses of Parliament – where the company demonstrated the detectors to members of parliament, peers of the realm, policy-makers, business leaders and acclaimed physicians.

Meet GrooveME, Argo Blockchain, Lancor Scientific and APQ Global at our event, London , 18 October 2018. Register here »
View full KMK profile View Profile

Kromek Group PLC Timeline

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use